Page last updated: 2024-09-03

modipafant and Cerebral Malaria

modipafant has been researched along with Cerebral Malaria in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Campos, RD; Lacerda-Queiroz, N; Quesniaux, VF; Rachid, MA; Rodrigues, DH; Soriani, FM; Sousa, LP; Teixeira, AL; Teixeira, MM; Vilela, MC	1

Other Studies

1 other study(ies) available for modipafant and Cerebral Malaria

Article	Year
Platelet-activating factor receptor is essential for the development of experimental cerebral malaria. The American journal of pathology, 2012, Volume: 180, Issue:1 Topics: Animals; Brain Chemistry; Caspase 3; Chemokines; Cytokines; Dihydropyridines; Imidazoles; Leukocytes; Lymphocyte Activation; Malaria, Cerebral; Mice; Mice, Inbred C57BL; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled	2012

Article

Year

Platelet-activating factor receptor is essential for the development of experimental cerebral malaria.

The American journal of pathology, 2012, Volume: 180, Issue:1

Topics: Animals; Brain Chemistry; Caspase 3; Chemokines; Cytokines; Dihydropyridines; Imidazoles; Leukocytes; Lymphocyte Activation; Malaria, Cerebral; Mice; Mice, Inbred C57BL; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled

2012